BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6609536)

  • 1. Biochemical basis for the differential effects of deoxycoformycin on human leukemias.
    Yu AL; Matsumoto S; Bleeker L; Alvarez A; Bakay B; Nyhan WL; Kung F
    Adv Exp Med Biol; 1984; 165 Pt B():305-8. PubMed ID: 6609536
    [No Abstract]   [Full Text] [Related]  

  • 2. 2'-deoxycoformycin toxicity in murine spleen lymphocytes.
    Earle MF; Glazer RI
    Mol Pharmacol; 1983 Jan; 23(1):165-70. PubMed ID: 6602939
    [No Abstract]   [Full Text] [Related]  

  • 3. Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin.
    Matsumoto SS; Yu AL; Yu J
    Cancer Invest; 1985; 3(3):225-33. PubMed ID: 3873981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
    Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical mechanisms of deoxycoformycin toxicity in chronic leukemias.
    Ganeshaguru K; Ho AD; Piga A; Catovsky D; Hoffbrand AV
    Leuk Res; 1987; 11(10):941-5. PubMed ID: 3500370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purine deoxyribonucleoside induced hepatotoxicity in the mouse.
    Renshaw J; Paine RM; Taylor GA; Harrap KR
    Adv Exp Med Biol; 1984; 165 Pt B():363-6. PubMed ID: 6609540
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.
    Begleiter A; Pugh L; Israels LG; Johnston JB
    Cancer Res; 1988 Jul; 48(14):3981-6. PubMed ID: 3260129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxycoformycin: neurological toxicity.
    Major PP; Agarwal RP; Kufe DW
    Cancer Chemother Pharmacol; 1981; 5(3):193-6. PubMed ID: 6975188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin.
    Brox L; Ng A; Pollock E; Belch A
    Cancer Res; 1984 Mar; 44(3):934-7. PubMed ID: 6607110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
    Kang GJ; Kimball AP
    Cancer Res; 1984 Feb; 44(2):461-6. PubMed ID: 6362851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxycoformycin resistant mammalian cells that overproduce adenosine deaminase.
    Hoffee PA; Hunt SW
    Adv Exp Med Biol; 1984; 165 Pt A():405-10. PubMed ID: 6609531
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicity and immunosuppressive activity of binary combinations of 2'-deoxycoformycin and 2'-deoxyadenosine.
    Paine RM; Weston BJ; Clink HM; Kohn J; Neville AM; McGhee KG; Harrap KR
    Cancer Treat Rep; 1981; 65(3-4):259-66. PubMed ID: 6972254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
    Plunkett W; Benjamin RS; Keating MJ; Freireich EJ
    Cancer Res; 1982 May; 42(5):2092-6. PubMed ID: 6175407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo inhibition of mouse liver methyltransferase enzymes following treatment with 2'-deoxycoformycin and 2'-deoxyadenosine.
    Renshaw J; Harrap KR
    Adv Exp Med Biol; 1986; 195 Pt B():673-5. PubMed ID: 3490129
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M; Kimura K
    Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells.
    Sylwestrowicz T; Piga A; Murphy P; Ganeshaguru K; Russell NH; Prentice HG; Hoffbrand AV
    Br J Haematol; 1982 Aug; 51(4):623-30. PubMed ID: 6980665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of deoxycoformycin (pentostatin) in refractory leukemias and lymphomas.
    Spiers AS
    Ann N Y Acad Sci; 1985; 451():138-41. PubMed ID: 3878115
    [No Abstract]   [Full Text] [Related]  

  • 18. dATP-mediated inhibition of DNA ligase by 2'-deoxycoformycin in T and B cell leukemia.
    Lamballe F; Le Prise PY; Le Gall E; David JC
    Leukemia; 1989 Feb; 3(2):97-103. PubMed ID: 2783473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA.
    Siaw MF; Coleman MS
    J Biol Chem; 1984 Aug; 259(15):9426-33. PubMed ID: 6204981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro.
    Begleiter A; Glazer RI; Israels LG; Pugh L; Johnston JB
    Cancer Res; 1987 May; 47(9):2498-503. PubMed ID: 3494509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.